Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.36M | -47.84M | -50.22M | -60.78M | -63.42M |
| Total Depreciation and Amortization | 2.44M | 2.34M | 2.20M | 2.20M | 1.95M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.06M | 16.62M | 23.30M | 37.76M | 41.29M |
| Change in Net Operating Assets | 3.91M | 5.02M | 2.66M | -1.05M | -2.72M |
| Cash from Operations | -26.95M | -23.86M | -22.06M | -21.87M | -22.89M |
| Capital Expenditure | -3.92M | -3.49M | -3.19M | -1.92M | -957.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 4.00K | 4.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.92M | -3.49M | -3.19M | -1.92M | -953.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -773.00K | -735.00K | -690.00K | -414.00K | -380.00K |
| Issuance of Common Stock | 26.03M | 26.02M | 29.14M | 41.13M | 41.15M |
| Repurchase of Common Stock | -309.00K | -72.00K | -72.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.37M | -1.19M | -489.00K | -1.56M | -1.74M |
| Cash from Financing | 23.76M | 24.21M | 28.07M | 39.16M | 39.03M |
| Foreign Exchange rate Adjustments | -146.00K | -235.00K | -244.00K | -232.00K | -148.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.26M | -3.37M | 2.58M | 15.15M | 15.03M |